Pathway Name Avg Num Perturbations Total Perturbations Num Entities Min Mean Truth Max Mean Truth Min Mean Within Max Mean Within Min Mean Any Max Mean Within BCR signaling pathway 126.0 12498.0 99.0 -0.707 0.045 1000.0 -1000.0 -0.049 -1000.0 IL4-mediated signaling events 124.0 11306.0 91.0 -1.269 1.044 1000.0 -1000.0 -0.06 -1000.0 TCR signaling in naïve CD8+ T cells 106.0 9936.0 93.0 -0.556 0.118 1000.0 -1000.0 -0.029 -1000.0 IL23-mediated signaling events 102.0 6155.0 60.0 -0.764 0.035 1000.0 -1000.0 -0.041 -1000.0 Nephrin/Neph1 signaling in the kidney podocyte 80.0 2749.0 34.0 -0.13 0.036 1000.0 -1000.0 -0.026 -1000.0 IL12-mediated signaling events 76.0 6680.0 87.0 -0.673 0.112 1000.0 -1000.0 -0.031 -1000.0 Calcineurin-regulated NFAT-dependent transcription in lymphocytes 63.0 4315.0 68.0 -0.57 0.119 1000.0 -1000.0 -0.04 -1000.0 Caspase cascade in apoptosis 59.0 4405.0 74.0 -0.157 0.121 1000.0 -1000.0 -0.019 -1000.0 Calcium signaling in the CD4+ TCR pathway 58.0 1812.0 31.0 -0.337 0.036 1000.0 -1000.0 -0.025 -1000.0 JNK signaling in the CD4+ TCR pathway 56.0 964.0 17.0 -0.218 0.034 1000.0 -1000.0 -0.019 -1000.0 E-cadherin signaling events 55.0 276.0 5.0 -0.075 0.036 1000.0 -1000.0 0.02 -1000.0 FAS signaling pathway (CD95) 52.0 2448.0 47.0 -0.089 0.075 1000.0 -1000.0 -0.024 -1000.0 IL27-mediated signaling events 51.0 2647.0 51.0 -0.263 0.17 1000.0 -1000.0 -0.036 -1000.0 Ras signaling in the CD4+ TCR pathway 51.0 873.0 17.0 -0.138 0.065 1000.0 -1000.0 -0.011 -1000.0 Stabilization and expansion of the E-cadherin adherens junction 46.0 3411.0 74.0 -0.075 0.082 1000.0 -1000.0 -0.038 -1000.0 E-cadherin signaling in the nascent adherens junction 44.0 3386.0 76.0 -0.089 0.053 1000.0 -1000.0 -0.034 -1000.0 HIV-1 Nef: Negative effector of Fas and TNF-alpha 43.0 1945.0 45.0 -0.163 0.075 1000.0 -1000.0 -0.022 -1000.0 a4b1 and a4b7 Integrin signaling 41.0 207.0 5.0 -0.025 0.014 1000.0 -1000.0 0.02 -1000.0 amb2 Integrin signaling 39.0 3220.0 82.0 -0.175 0.045 1000.0 -1000.0 -0.013 -1000.0 IL2 signaling events mediated by PI3K 39.0 2277.0 58.0 -0.142 0.062 1000.0 -1000.0 -0.024 -1000.0 Glucocorticoid receptor regulatory network 38.0 4379.0 114.0 -0.424 0.245 1000.0 -1000.0 -0.036 -1000.0 Signaling events regulated by Ret tyrosine kinase 38.0 3165.0 82.0 -0.065 0.036 1000.0 -1000.0 -0.033 -1000.0 Thromboxane A2 receptor signaling 37.0 3948.0 105.0 -0.121 0.059 1000.0 -1000.0 -0.027 -1000.0 IFN-gamma pathway 37.0 2574.0 68.0 -0.113 0.046 1000.0 -1000.0 -0.047 -1000.0 Class I PI3K signaling events 37.0 2736.0 73.0 -0.37 0.07 1000.0 -1000.0 -0.02 -1000.0 Angiopoietin receptor Tie2-mediated signaling 37.0 3334.0 88.0 -0.204 0.047 1000.0 -1000.0 -0.048 -1000.0 Paxillin-independent events mediated by a4b1 and a4b7 36.0 1365.0 37.0 -0.208 0.051 1000.0 -1000.0 -0.012 -1000.0 S1P4 pathway 36.0 905.0 25.0 -0.105 0.046 1000.0 -1000.0 -0.008 -1000.0 Syndecan-1-mediated signaling events 35.0 1211.0 34.0 -0.09 0.036 1000.0 -1000.0 -0.013 -1000.0 Endothelins 35.0 3391.0 96.0 -0.159 0.037 1000.0 -1000.0 -0.027 -1000.0 IL2 signaling events mediated by STAT5 35.0 778.0 22.0 -0.156 0.037 1000.0 -1000.0 -0.018 -1000.0 ceramide signaling pathway 32.0 1572.0 49.0 -0.096 0.051 1000.0 -1000.0 -0.015 -1000.0 Fc-epsilon receptor I signaling in mast cells 31.0 3091.0 97.0 -0.101 0.061 1000.0 -1000.0 -0.045 -1000.0 E-cadherin signaling in keratinocytes 31.0 1351.0 43.0 -0.075 0.038 1000.0 -1000.0 -0.015 -1000.0 FOXA2 and FOXA3 transcription factor networks 29.0 1342.0 46.0 -0.423 0.041 1000.0 -1000.0 -0.041 -1000.0 Syndecan-4-mediated signaling events 28.0 1925.0 67.0 -0.164 0.047 1000.0 -1000.0 -0.027 -1000.0 HIF-1-alpha transcription factor network 27.0 2071.0 76.0 -0.092 0.104 1000.0 -1000.0 -0.005 -1000.0 LPA receptor mediated events 27.0 2807.0 102.0 -0.079 0.046 1000.0 -1000.0 -0.046 -1000.0 Visual signal transduction: Cones 25.0 982.0 38.0 -0.137 0.042 1000.0 -1000.0 -0.006 -1000.0 Glypican 1 network 24.0 1177.0 48.0 -0.213 0.036 1000.0 -1000.0 -0.021 -1000.0 Osteopontin-mediated events 23.0 876.0 38.0 -0.035 0.051 1000.0 -1000.0 -0.01 -1000.0 TRAIL signaling pathway 23.0 1139.0 48.0 -0.026 0.056 1000.0 -1000.0 -0.012 -1000.0 Atypical NF-kappaB pathway 23.0 741.0 31.0 -0.129 0.05 1000.0 -1000.0 -0.006 -1000.0 Regulation of p38-alpha and p38-beta 23.0 1248.0 54.0 -0.224 0.074 1000.0 -1000.0 -0.036 -1000.0 Visual signal transduction: Rods 23.0 1224.0 52.0 -0.137 0.04 1000.0 -1000.0 -0.007 -1000.0 Aurora C signaling 21.0 148.0 7.0 -0.051 0.033 1000.0 -1000.0 -0.006 -1000.0 RXR and RAR heterodimerization with other nuclear receptor 21.0 1121.0 52.0 -0.172 0.069 1000.0 -1000.0 -0.022 -1000.0 Ephrin A reverse signaling 20.0 140.0 7.0 -0.009 0.026 1000.0 -1000.0 -0.0 -1000.0 Arf6 signaling events 20.0 1241.0 62.0 -0.097 0.075 1000.0 -1000.0 -0.033 -1000.0 Ceramide signaling pathway 20.0 1566.0 76.0 -0.096 0.082 1000.0 -1000.0 -0.024 -1000.0 IL6-mediated signaling events 20.0 1513.0 75.0 -0.185 0.059 1000.0 -1000.0 -0.038 -1000.0 Paxillin-dependent events mediated by a4b1 19.0 717.0 36.0 -0.043 0.061 1000.0 -1000.0 -0.03 -1000.0 EPHB forward signaling 18.0 1569.0 85.0 -0.054 0.067 1000.0 -1000.0 -0.039 -1000.0 Plasma membrane estrogen receptor signaling 18.0 1616.0 86.0 -0.054 0.064 1000.0 -1000.0 -0.027 -1000.0 Signaling events mediated by PTP1B 16.0 1260.0 76.0 -0.236 0.064 1000.0 -1000.0 -0.015 -1000.0 EPO signaling pathway 16.0 933.0 55.0 -0.034 0.056 1000.0 -1000.0 -0.014 -1000.0 Signaling events mediated by the Hedgehog family 15.0 785.0 52.0 -0.194 0.056 1000.0 -1000.0 -0.016 -1000.0 Nectin adhesion pathway 15.0 986.0 63.0 -0.166 0.065 1000.0 -1000.0 -0.028 -1000.0 Integrins in angiogenesis 15.0 1342.0 84.0 -0.129 0.075 1000.0 -1000.0 -0.021 -1000.0 PDGFR-beta signaling pathway 15.0 1475.0 97.0 -0.294 0.089 1000.0 -1000.0 -0.026 -1000.0 Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met) 14.0 1244.0 85.0 -0.034 0.075 1000.0 -1000.0 -0.028 -1000.0 BMP receptor signaling 14.0 1137.0 81.0 -0.136 0.074 1000.0 -1000.0 -0.013 -1000.0 Sphingosine 1-phosphate (S1P) pathway 13.0 379.0 28.0 -0.105 0.067 1000.0 -1000.0 -0.012 -1000.0 Cellular roles of Anthrax toxin 13.0 534.0 39.0 -0.12 0.042 1000.0 -1000.0 -0.013 -1000.0 p75(NTR)-mediated signaling 13.0 1711.0 125.0 -0.096 0.09 1000.0 -1000.0 -0.03 -1000.0 Role of Calcineurin-dependent NFAT signaling in lymphocytes 13.0 1097.0 83.0 -0.091 0.068 1000.0 -1000.0 -0.011 -1000.0 LPA4-mediated signaling events 12.0 146.0 12.0 -0.045 0.01 1000.0 -1000.0 -0.012 -1000.0 Neurotrophic factor-mediated Trk receptor signaling 12.0 1537.0 120.0 -0.07 0.086 1000.0 -1000.0 -0.028 -1000.0 Signaling events mediated by Stem cell factor receptor (c-Kit) 12.0 985.0 78.0 -0.077 0.08 1000.0 -1000.0 -0.032 -1000.0 Noncanonical Wnt signaling pathway 11.0 311.0 26.0 -0.007 0.039 1000.0 -1000.0 -0.026 -1000.0 Syndecan-2-mediated signaling events 11.0 826.0 69.0 -0.164 0.059 1000.0 -1000.0 -0.019 -1000.0 Ephrin B reverse signaling 11.0 545.0 48.0 -0.1 0.046 1000.0 -1000.0 -0.026 -1000.0 ErbB2/ErbB3 signaling events 10.0 710.0 65.0 -0.024 0.061 1000.0 -1000.0 -0.031 -1000.0 IL1-mediated signaling events 10.0 667.0 62.0 -0.029 0.085 1000.0 -1000.0 -0.02 -1000.0 Canonical Wnt signaling pathway 10.0 510.0 51.0 -0.025 0.073 1000.0 -1000.0 -0.03 -1000.0 EGFR-dependent Endothelin signaling events 10.0 223.0 21.0 -0.021 0.051 1000.0 -1000.0 -0.03 -1000.0 Presenilin action in Notch and Wnt signaling 9.0 600.0 61.0 -0.062 0.091 1000.0 -1000.0 -0.025 -1000.0 TCGA08_retinoblastoma 9.0 75.0 8.0 -0.01 0.036 1000.0 -1000.0 -0.004 -1000.0 mTOR signaling pathway 8.0 446.0 53.0 -0.019 0.055 1000.0 -1000.0 -0.021 -1000.0 Signaling mediated by p38-gamma and p38-delta 8.0 126.0 15.0 -0.004 0.035 1000.0 -1000.0 -0.017 -1000.0 Aurora B signaling 8.0 556.0 67.0 -0.091 0.092 1000.0 -1000.0 -0.022 -1000.0 Canonical NF-kappaB pathway 7.0 295.0 39.0 -0.05 0.075 1000.0 -1000.0 -0.014 -1000.0 Lissencephaly gene (LIS1) in neuronal migration and development 7.0 389.0 54.0 -0.073 0.059 1000.0 -1000.0 -0.011 -1000.0 Signaling events mediated by HDAC Class I 7.0 784.0 104.0 -0.066 0.083 1000.0 -1000.0 -0.037 -1000.0 Effects of Botulinum toxin 7.0 186.0 26.0 -0.025 0.046 1000.0 -1000.0 -0.002 -1000.0 Glypican 2 network 6.0 27.0 4.0 0.026 0.037 1000.0 -1000.0 0.022 -1000.0 TCGA08_rtk_signaling 6.0 164.0 26.0 -0.042 0.083 1000.0 -1000.0 -0.01 -1000.0 Insulin Pathway 6.0 463.0 74.0 -0.058 0.085 1000.0 -1000.0 -0.026 -1000.0 Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 6.0 210.0 33.0 -0.013 0.08 1000.0 -1000.0 -0.013 -1000.0 Class IB PI3K non-lipid kinase events 6.0 18.0 3.0 -0.028 0.028 1000.0 -1000.0 -0.023 -1000.0 FoxO family signaling 5.0 343.0 64.0 -0.41 0.099 1000.0 -1000.0 -0.031 -1000.0 Signaling mediated by p38-alpha and p38-beta 5.0 230.0 44.0 -0.008 0.048 1000.0 -1000.0 -0.009 -1000.0 Wnt signaling 5.0 41.0 7.0 -0.007 0.032 1000.0 -1000.0 0.002 -1000.0 Regulation of Telomerase 5.0 584.0 102.0 -0.105 0.079 1000.0 -1000.0 -0.024 -1000.0 S1P3 pathway 5.0 225.0 42.0 -0.033 0.056 1000.0 -1000.0 -0.019 -1000.0 Regulation of Androgen receptor activity 5.0 391.0 70.0 -0.053 0.049 1000.0 -1000.0 -0.026 -1000.0 Regulation of nuclear SMAD2/3 signaling 4.0 589.0 136.0 -0.119 0.124 1000.0 -1000.0 -0.036 -1000.0 ErbB4 signaling events 4.0 281.0 69.0 -0.039 0.056 1000.0 -1000.0 -0.015 -1000.0 PLK1 signaling events 4.0 421.0 85.0 -0.008 0.071 1000.0 -1000.0 -0.023 -1000.0 Class I PI3K signaling events mediated by Akt 4.0 303.0 68.0 -0.053 0.068 1000.0 -1000.0 -0.018 -1000.0 HIF-2-alpha transcription factor network 4.0 201.0 43.0 -0.152 0.155 1000.0 -1000.0 -0.042 -1000.0 S1P1 pathway 4.0 179.0 36.0 -0.003 0.038 1000.0 -1000.0 -0.019 -1000.0 Signaling events mediated by PRL 4.0 149.0 34.0 -0.054 0.078 1000.0 -1000.0 -0.024 -1000.0 p38 MAPK signaling pathway 4.0 185.0 44.0 -0.01 0.059 1000.0 -1000.0 -0.01 -1000.0 Hedgehog signaling events mediated by Gli proteins 3.0 207.0 65.0 -0.003 0.083 1000.0 -1000.0 -0.019 -1000.0 Arf6 downstream pathway 3.0 151.0 43.0 -0.052 0.065 1000.0 -1000.0 -0.03 -1000.0 Reelin signaling pathway 3.0 176.0 56.0 -0.013 0.079 1000.0 -1000.0 -0.014 -1000.0 Retinoic acid receptors-mediated signaling 3.0 198.0 58.0 -0.031 0.069 1000.0 -1000.0 -0.028 -1000.0 Syndecan-3-mediated signaling events 3.0 134.0 35.0 -0.015 0.09 1000.0 -1000.0 -0.017 -1000.0 Signaling events mediated by VEGFR1 and VEGFR2 3.0 469.0 125.0 -0.07 0.087 1000.0 -1000.0 -0.019 -1000.0 IGF1 pathway 3.0 179.0 57.0 -0.025 0.086 1000.0 -1000.0 -0.024 -1000.0 Arf1 pathway 3.0 202.0 54.0 -0.006 0.052 1000.0 -1000.0 -0.011 -1000.0 Coregulation of Androgen receptor activity 2.0 223.0 76.0 -0.02 0.062 1000.0 -1000.0 -0.016 -1000.0 Insulin-mediated glucose transport 2.0 67.0 32.0 -0.0 0.066 1000.0 -1000.0 -0.006 -1000.0 PDGFR-alpha signaling pathway 2.0 119.0 44.0 -0.022 0.071 1000.0 -1000.0 -0.026 -1000.0 Signaling events mediated by HDAC Class III 2.0 100.0 40.0 -0.058 0.059 1000.0 -1000.0 -0.037 -1000.0 Nongenotropic Androgen signaling 2.0 147.0 52.0 -0.037 0.058 1000.0 -1000.0 -0.015 -1000.0 Arf6 trafficking events 2.0 205.0 71.0 -0.055 0.066 1000.0 -1000.0 -0.032 -1000.0 FOXM1 transcription factor network 2.0 116.0 51.0 -0.016 0.249 1000.0 -1000.0 -0.059 -1000.0 Signaling events mediated by HDAC Class II 1.0 149.0 75.0 -0.04 0.092 1000.0 -1000.0 -0.015 -1000.0 Aurora A signaling 1.0 94.0 60.0 -0.0 0.076 1000.0 -1000.0 -0.007 -1000.0 S1P5 pathway 1.0 25.0 17.0 -0.03 0.04 1000.0 -1000.0 -0.007 -1000.0 VEGFR1 specific signals 1.0 106.0 56.0 -0.044 0.086 1000.0 -1000.0 -0.025 -1000.0 Rapid glucocorticoid signaling 1.0 36.0 20.0 -0.009 0.042 1000.0 -1000.0 -0.0 -1000.0 Regulation of cytoplasmic and nuclear SMAD2/3 signaling 0.0 6.0 23.0 0.007 0.071 1000.0 -1000.0 -0.013 -1000.0 BARD1 signaling events 0.0 50.0 57.0 -0.08 0.093 1000.0 -1000.0 -0.035 -1000.0 PLK2 and PLK4 events 0.0 2.0 3.0 0.018 -1000.0 1000.0 -1000.0 -0.003 -1000.0 Circadian rhythm pathway 0.0 6.0 22.0 -0.012 0.083 1000.0 -1000.0 -0.016 -1000.0 TCGA08_p53 0.0 1.0 7.0 -0.011 0.032 1000.0 -1000.0 -0.004 -1000.0 Sumoylation by RanBP2 regulates transcriptional repression 0.0 5.0 27.0 -0.0 0.084 1000.0 -1000.0 -0.018 -1000.0 Alternative NF-kappaB pathway 0.0 0.0 13.0 -0.0 0.092 1000.0 -1000.0 -0.0 -1000.0 Total 2744 171450 7203 -15.7125607227 -990.305480113 131000 -131000 -2.77298993347 -131000